Prescription drug expenditure in the US was close to 378 billion dollars in the US, in 2021, as reported by The Centers for Medicare and Medicaid. This statistic has sparked our interest at Elsevier to delve deeper into drug pricing analysis and shed light – on the impact – that delivering drug pricing data daily can have on your business.
In the ever-evolving landscape of the pharmaceutical industry, it has become crucial to understand the dynamic nature of drug price data.
Read our Drug Pricing Analytics Brief to gain insight into the findings from our analysis on the significant business implications that can arise from relying on outdated drug pricing data.
Cookies are used by this site. To decline or learn more, visit our cookie notice.